Medicus Pharma (MDCXW) Stock Analysis
NASDAQHealthcareBiotechnology
What Medicus Pharma does
Medicus Pharma Ltd. is a biotech life sciences company, which focuses on accelerating the clinical development programs of novel and disruptive therapeutic assets. It develops a product, SkinJectTM, with an indication for basal cell carcinoma. The company was founded on April 30, 2008 and is headquartered in Toronto, Canada.
Key metrics
ETFs linked to MDCXW
Broad-market and Healthcare sector ETFs an investor holding Medicus Pharma is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how MDCXW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze MDCXW in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Medicus Pharma?
- Medicus Pharma trades under the ticker MDCXW on NASDAQ.
- Which exchange is MDCXW listed on?
- MDCXW is listed on NASDAQ.
- What sector does Medicus Pharma operate in?
- Medicus Pharma is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze MDCXW in a portfolio?
- PortView shows MDCXW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.